These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3950060)

  • 21. Evaluation of the renal and auditory function of neonates treated with amikacin.
    Parini R; Rusconi F; Cavanna G; Vigliani E; Cornacchia L; Assael BM
    Dev Pharmacol Ther; 1982; 5(1-2):33-46. PubMed ID: 7151635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of haemodialysis as a protective technique for preventing high daily dose amikacin nephrotoxicity: an experimental study in an ovine model.
    Pouzot-Nevoret C; Magnin M; Ayoub JY; Bourguignon L; Maire P; Wertz D; Goy-Thollot I; Barthélemy A; Boselli E; Allaouchiche B; Bonnet-Garin JM
    Int J Antimicrob Agents; 2017 Aug; 50(2):148-154. PubMed ID: 28689868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ototoxicity and nephrotoxicity of amikacin: an overview of phase II and phase III experience in the United States.
    Lane AZ; Wright GE; Blair DC
    Am J Med; 1977 Jun; 62(6):911-8. PubMed ID: 868905
    [No Abstract]   [Full Text] [Related]  

  • 24. Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms.
    Yu VL; Rhame FS; Pesanti EL; Axline SG
    JAMA; 1977 Aug; 238(9):943-7. PubMed ID: 328950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled comparison of amikacin and gentamicin.
    Smith CR; Baughman KL; Edwards CQ; Rogers JF; Lietman PS
    N Engl J Med; 1977 Feb; 296(7):349-53. PubMed ID: 319355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amikacin therapy for serious gram-negative bacillary infections.
    Meyer RD; Lewis RP; Carmalt ED; Finegold SM
    Ann Intern Med; 1975 Dec; 83(6):790-800. PubMed ID: 1200524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amikacin serum concentrations: prediction of levels and dosage guidelines.
    Sarubbi FA; Hull JH
    Ann Intern Med; 1978 Nov; 89(5 Pt 1):612-8. PubMed ID: 717929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative nephrotoxicity of SCH 21420 and amikacin in rats.
    Rankin LI; Luft FC; Yum MN; Sloan RS; Dinwiddie CB; Isaacs LL
    Antimicrob Agents Chemother; 1979 Oct; 16(4):491-4. PubMed ID: 518078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic.
    Lode H; Grunert K; Koeppe P; Langmaack H
    J Infect Dis; 1976 Nov; 134 SUPPL():S316-22. PubMed ID: 825589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
    Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetics and clinical experience with amikacin. A new aminoglycoside antibiotic].
    Lode H; Grunert K; Koeppe P; Langmaack H
    Dtsch Med Wochenschr; 1976 Sep; 101(36):1312-7. PubMed ID: 782811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
    Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
    Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia.
    Bernabeu-Wittel M; Pichardo C; García-Curiel A; Pachón-Ibáñez ME; Ibáñez-Martínez J; Jiménez-Mejías ME; Pachón J
    Clin Microbiol Infect; 2005 Apr; 11(4):319-25. PubMed ID: 15760430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition kinetics of amikacin in patients with renal impairment after intramuscular administration.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Molina HD
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):271-5. PubMed ID: 7107075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical application of amikacin dosage based upon lean body mass in patients with different renal function.
    Wagenvoort JH; Fieren MW; Goessens WH; Michel MF
    Chemotherapy; 1984; 30(2):69-75. PubMed ID: 6697814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin].
    Olier B; Morin JP; Thomas N; Fillastre JP
    Pathol Biol (Paris); 1988 Jun; 36(6):795-800. PubMed ID: 3047639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amikacin nephrotoxicity in the rat.
    Houghton DC; Plamp CE; Gilbert DN; Kohlhepp SJ; Bennett WM; Porter GA; DeFehr J; Webb M
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):277-91. PubMed ID: 7217852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin dosing and target attainment in children.
    Hwang D; Chiu NC; Chang L; Peng CC; Huang DT; Huang FY; Chi H
    J Microbiol Immunol Infect; 2017 Aug; 50(4):494-499. PubMed ID: 26462708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli.
    Mathias RG; Ronald AR; Gurwith MJ; McCullough DW; Stiver HG; Berger J; Cates CY; Fox LM; Lank BA
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-401. PubMed ID: 825590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Kinetics of multiple-dose amikacin in the newborn infant].
    Olivesi A; Camboulives J; Charrel C; Unal D
    Ann Anesthesiol Fr; 1981; 22(2):212-8. PubMed ID: 6115610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.